Wall Street is 'guessing the intention': will it be a 50 or 25 basis point rate cut? The next 12 hours will reveal the answer.
If there is no media report about a 25 basis point interest rate hike before Wednesday, the possibility of a 50 basis point interest rate hike on Wednesday will increase further. The media trend in the next 12 hours is crucial and may ultimately determine market pricing.
(INSM) - Analyzing Insmed's Short Interest
Boeing Strike Leads Analysts to Estimate Effect on Cash Flow
'Wall Street Bear' speaks out: Harris' tax reform plan could be the financial terminator, and economic recession cannot be avoided!
Paulson recently stated that if Democratic presidential candidate Harris implements the proposed tax plan, the financial markets will collapse and the economy will enter a recession. Earlier this year, insiders revealed that if Trump wins the election this year, he will recruit Paulson as Secretary of the Treasury.
Bank of America: U.S. stock market momentum will be limited until the direction of U.S. employment becomes clear.
Bank of America strategist stated that the stock market may trade sideways and fluctuate before clear signs of weakness or strength in US employment data are shown.
Has the pullback in the US stock market ended? Deutsche Bank raised its target price for the s&p 500: three major bullish factors support the US stock market to reach new highs.
Deutsche Bank has raised its year-end target for the S&P 500 index from 5500 points to 5750 points, citing increased stock buybacks, strong corporate earnings, and strong inflow of funds driven by strong risk preferences. According to Deutsche Bank analysts, the recent two-month period of volatile pullback in the US stock market is now basically over, and the US stock market will continue to rise in the future.
Put signals are flashing! The U.S. stocks rebound, but panic is gradually rising in the $9.5 trillion ETF market.
As anxiety intensifies, the volume of the largest inverse ETF increases.
Here's How Much $1000 Invested In Insmed 10 Years Ago Would Be Worth Today
US stocks rebounded, shocking Wall Street! This week's focus will shift to the "Hart's first debate" and CPI data.
①After last week's sharp drop in US stocks triggered by economic concerns, a new wave of bottom-buying stimulated a rebound in the stock market on Monday; ②Looking ahead to this week, traders are closely watching the US inflation data scheduled for release on Wednesday, in search of clues on the scale of the Fed's interest rate cuts; ③In addition, the first presidential debate between Harris and Trump on Tuesday night also attracted the attention of many industry insiders.
Cantor Fitzgerald Reiterates Overweight on Insmed
Reported Earlier, Vaxcyte Prices $1.3B Public Offering Of 10,194,175 Common Shares And Pre-Funded Warrants At $103/Share
Market Mover | Vaxcyte Shares Surge 36% After Positive Topline Data from 1/2 Study of VAX-31 Vaccine
Vaxcyte Announced Topline Results From Phase 1/2 Study Of VAX-31, The Company's 31-valent Pneumococcal Conjugate Vaccine Candidate; At All Doses, VAX-31 Demonstrated Robust Opsonophagocytic Activity Immune Responses For All 31 Serotypes
Peering Into Vaxcyte's Recent Short Interest
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $9,600 Today
$1000 Invested In Insmed 10 Years Ago Would Be Worth This Much Today
Morgan Stanley's 20 Top Stock Picks
$100 Invested In FTAI Aviation 5 Years Ago Would Be Worth This Much Today
Insmed Analyst Ratings
$100 Invested In Insmed 5 Years Ago Would Be Worth This Much Today